Sarepta Therapeutics
Patents, Design & Utilities
Last updated:
List of all Sarepta Therapeutics patents 44 in total
| Status | Patent |
|---|---|
Grant | Utility: Exon skipping oligomer conjugates for muscular dystrophy Filling date: 5 Sep 2025 Issue date: 26 Jul 2022 |
Grant | Utility: Processes for preparing oligomers Filling date: 5 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Exon skipping oligomer conjugates for muscular dystrophy Filling date: 5 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Exon skipping oligomer conjugates for muscular dystrophy Filling date: 5 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN Filling date: 5 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF Filling date: 5 Sep 2025 Issue date: 3 Feb 2022 |
Grant | Utility: Antisense-induced exon2 inclusion in acid alpha-glucosidase Filling date: 5 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 20 Jan 2022 |
Grant | Utility: Functionally-modified oligonucleotides and subunits thereof Filling date: 5 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: Adeno-Associated Virus Vector Delivery for Muscular Dystrophies Filling date: 5 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: ADENO-ASSOCIATED VIRUS ANTIBODIES AND FRAGMENTS THEREOF Filling date: 5 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: TRIMERIC PEPTIDES FOR ANTISENSE DELIVERY Filling date: 5 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: METHODS AND COMPOUNDS FOR TREATMENT OF LYMPHOCYTE-RELATED DISEASES AND CONDITIONS Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: CHIMERIC PEPTIDES FOR ANTISENSE DELIVER Filling date: 5 Sep 2025 Issue date: 26 Aug 2021 |
Grant | Utility: Oligonucleotide analogues targeting human LMNA Filling date: 5 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: DsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups Filling date: 5 Sep 2025 Issue date: 27 Jul 2021 |
Application | Utility: EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: MODIFIED ANTISENSE OLIGOMERS FOR EXON INCLUSION IN SPINAL MUSCULAR ATROPHY Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ANTISENSE-INDUCED EXON EXCLUSION IN TYPE VII COLLAGEN Filling date: 5 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: Combination Therapies for Treating Muscular Dystrophy Filling date: 5 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS Filling date: 5 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Peptide Oligonucleotide Conjugates Filling date: 5 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY Filling date: 5 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: ANTISENSE OLIGOMER COMPOUNDS Filling date: 5 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY Filling date: 5 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA Filling date: 5 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METHODS FOR TREATING MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: Cell-Penetrating Peptides For Antisense Delivery Filling date: 5 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: Peptide Oligonucleotide Conjugates Filling date: 5 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: Peptide Oligonucleotide Conjugates Filling date: 5 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: COMBINATION THERAPIES FOR TREATING MUSCULAR DYSTROPHY Filling date: 5 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: BICYCLIC PEPTIDE OLIGONUCLEOTIDE CONJUGATES Filling date: 5 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY Filling date: 5 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA Filling date: 5 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: Functionally-Modified Oligonucleotides And Subunits Thereof Filling date: 5 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS Filling date: 5 Sep 2025 Issue date: 12 Mar 2020 |
Showing 1 to 44 of 44 patents.